森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/17 | 1,877 | 1,891 | 1,877 | 1,885 | -8 | -0.4% | 600 |
| 2022/05/16 | 1,885 | 1,893 | 1,877 | 1,893 | +8 | +0.4% | 1,000 |
| 2022/05/13 | 1,884 | 1,885 | 1,877 | 1,885 | -9 | -0.5% | 400 |
| 2022/05/12 | 1,885 | 1,898 | 1,877 | 1,894 | +9 | +0.5% | 700 |
| 2022/05/11 | 1,876 | 1,897 | 1,876 | 1,885 | +9 | +0.5% | 700 |
| 2022/05/10 | 1,900 | 1,900 | 1,876 | 1,876 | -24 | -1.3% | 1,200 |
| 2022/05/09 | 1,876 | 1,917 | 1,876 | 1,900 | +24 | +1.3% | 4,200 |
| 2022/05/06 | 1,865 | 1,876 | 1,863 | 1,876 | -2 | -0.1% | 1,700 |
| 2022/05/02 | 1,870 | 1,878 | 1,867 | 1,878 | +7 | +0.4% | 1,300 |
| 2022/04/28 | 1,872 | 1,872 | 1,871 | 1,871 | -1 | -0.1% | 1,300 |
| 2022/04/27 | 1,875 | 1,877 | 1,872 | 1,872 | -5 | -0.3% | 1,400 |
| 2022/04/26 | 1,875 | 1,883 | 1,875 | 1,877 | -6 | -0.3% | 500 |
| 2022/04/25 | 1,881 | 1,883 | 1,875 | 1,883 | +8 | +0.4% | 1,200 |
| 2022/04/22 | 1,875 | 1,883 | 1,875 | 1,875 | -9 | -0.5% | 900 |
| 2022/04/21 | 1,884 | 1,885 | 1,876 | 1,884 | ±0 | ±0% | 800 |
| 2022/04/20 | 1,877 | 1,884 | 1,874 | 1,884 | +7 | +0.4% | 2,000 |
| 2022/04/19 | 1,882 | 1,884 | 1,877 | 1,877 | -5 | -0.3% | 600 |
| 2022/04/18 | 1,873 | 1,882 | 1,873 | 1,882 | ±0 | ±0% | 1,200 |
| 2022/04/15 | 1,882 | 1,882 | 1,873 | 1,882 | -1 | -0.1% | 1,400 |
| 2022/04/14 | 1,880 | 1,883 | 1,880 | 1,883 | +3 | +0.2% | 500 |
| 2022/04/13 | 1,871 | 1,880 | 1,871 | 1,880 | +4 | +0.2% | 1,100 |
| 2022/04/12 | 1,875 | 1,882 | 1,874 | 1,876 | -1 | -0.1% | 800 |
| 2022/04/11 | 1,876 | 1,877 | 1,875 | 1,877 | ±0 | ±0% | 500 |
| 2022/04/08 | 1,880 | 1,885 | 1,877 | 1,877 | -8 | -0.4% | 1,200 |
| 2022/04/07 | 1,885 | 1,885 | 1,883 | 1,885 | ±0 | ±0% | 400 |
| 2022/04/06 | 1,886 | 1,891 | 1,885 | 1,885 | -1 | -0.1% | 1,100 |
| 2022/04/05 | 1,880 | 1,894 | 1,876 | 1,886 | +6 | +0.3% | 2,200 |
| 2022/04/04 | 1,885 | 1,886 | 1,876 | 1,880 | -6 | -0.3% | 1,900 |
| 2022/04/01 | 1,886 | 1,886 | 1,883 | 1,886 | ±0 | ±0% | 1,300 |
| 2022/03/31 | 1,888 | 1,892 | 1,886 | 1,886 | -7 | -0.4% | 400 |
| 2022/03/30 | 1,876 | 1,903 | 1,876 | 1,893 | -47 | -2.4% | 2,700 |
| 2022/03/29 | 1,930 | 1,944 | 1,929 | 1,940 | -3 | -0.2% | 1,600 |
| 2022/03/28 | 1,928 | 1,943 | 1,928 | 1,943 | +13 | +0.7% | 2,400 |
| 2022/03/25 | 1,925 | 1,930 | 1,924 | 1,930 | +5 | +0.3% | 1,200 |
| 2022/03/24 | 1,925 | 1,925 | 1,916 | 1,925 | -1 | -0.1% | 1,300 |
| 2022/03/23 | 1,926 | 1,926 | 1,925 | 1,926 | ±0 | ±0% | 1,600 |
| 2022/03/22 | 1,930 | 1,931 | 1,926 | 1,926 | -1 | -0.1% | 900 |
| 2022/03/18 | 1,914 | 1,927 | 1,914 | 1,927 | +13 | +0.7% | 500 |
| 2022/03/17 | 1,927 | 1,936 | 1,914 | 1,914 | -13 | -0.7% | 2,100 |
| 2022/03/16 | 1,922 | 1,928 | 1,922 | 1,927 | +2 | +0.1% | 800 |
| 2022/03/15 | 1,920 | 1,925 | 1,920 | 1,925 | +3 | +0.2% | 1,200 |
| 2022/03/14 | 1,923 | 1,923 | 1,914 | 1,922 | - | - | 400 |
| 2022/03/11 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2022/03/10 | 1,912 | 1,913 | 1,912 | 1,913 | +3 | +0.2% | 300 |
| 2022/03/09 | 1,913 | 1,914 | 1,904 | 1,910 | -1 | -0.1% | 2,400 |
| 2022/03/08 | 1,924 | 1,924 | 1,911 | 1,911 | -13 | -0.7% | 1,500 |
| 2022/03/07 | 1,914 | 1,924 | 1,914 | 1,924 | +4 | +0.2% | 700 |
| 2022/03/04 | 1,915 | 1,922 | 1,915 | 1,920 | -4 | -0.2% | 400 |
| 2022/03/03 | 1,915 | 1,924 | 1,910 | 1,924 | +9 | +0.5% | 1,200 |
| 2022/03/02 | 1,914 | 1,915 | 1,907 | 1,915 | +1 | +0.1% | 1,600 |
751～
800
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 211,900円 | +0.3% | +9.2% | 3.07% | 12.04倍 | 0.71倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ＰＲＩＳＭＢｉｏ | 24,700円 | +14.8% | - | 0.00% | - | 2.96倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
| ＮＡＮＯ | 12,600円 | -30.6% | - | 0.00% | - | 3.27倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
| ケイファーマ | 75,200円 | - | - | 0.00% | - | 3.86倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞による再生医療と創薬の２本柱。中枢神経系が得意領域 |
| シンバイオ | 16,700円 | -24.2% | - | 0.00% | - | 2.10倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬ＢＣＶの開発に注力 |
市場注目の銘柄
チャート関連のコラム
